Lakewood-Amedex Biotherapeutics, Inc. (LABT) vs Alaunos Therapeutics, Inc. (TCRT)
A side-by-side comparison of Lakewood-Amedex Biotherapeutics, Inc. and Alaunos Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LABT
Lakewood-Amedex Biotherapeutics, Inc.
$0.87HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TCRT
Alaunos Therapeutics, Inc.
$0.74HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LABT vs TCRT
growth of $100 · dividends reinvested · last 1yLABT -99.0% (-99.0%/yr)TCRT -70.9% (-70.9%/yr)TCRT compounded faster over this window
Log scale — wide-divergence pair
LABT TCRT
LABT vs TCRT: by the numbers
- •TCRT is the larger company ($2M vs $2M market cap).
- •Both run net losses; LABT's is the smaller (0.00% vs -133666.67% net margin).
Metrics side by side
Valuation
| Metric | LABT | TCRT |
|---|---|---|
| P/S ratio | N/A | 604.35 |
| P/B ratio | 0.35 | 2.78 |
Profitability
| Metric | LABT | TCRT |
|---|---|---|
| Gross margin | 0.00% | -27160.00% |
| Operating margin | 0.00% | -84500.00% |
| Net margin | 0.00% | -133666.67% |
| ROE | -169.64% | -615.03% |
| ROIC | -163.98% | -622.39% |
Growth (annualized)
| Metric | LABT | TCRT |
|---|---|---|
| Total return CAGR (5Y) | N/A | -69.13% |
Go deeper
Dig into the metrics
Lakewood-Amedex Biotherapeutics ROEAlaunos Therapeutics ROELakewood-Amedex Biotherapeutics operating marginAlaunos Therapeutics operating marginLakewood-Amedex Biotherapeutics revenue growthAlaunos Therapeutics revenue growthLakewood-Amedex Biotherapeutics free cash flowAlaunos Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.